Authors' Reply to Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"

被引：1

作者：

Neuberger, Edward E. ^{[1
]}

Carlson, Josh J. ^{[2
]}

Veenstra, David L. ^{[2
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

[2] Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA

来源：

PHARMACOECONOMICS | 2021年 / 39卷 / 04期

关键词：

UTILITY;

D O I：

10.1007/s40273-021-01006-9

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：477 / 478

页数：2

共 50 条

[1] Authors’ Reply to Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
Edward E. Neuberger
Josh J. Carlson
David L. Veenstra
[J]. PharmacoEconomics, 2021, 39 : 477 - 478
[2] Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"
Hollenack, Kelly
Marshall, Jade
[J]. PHARMACOECONOMICS, 2021, 39 (04) : 473 - 475
[3] Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
Kelly Hollenack
Jade Marshall
[J]. PharmacoEconomics, 2021, 39 : 473 - 475
[4] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Edward E. Neuberger
Josh J. Carlson
David L. Veenstra
[J]. PharmacoEconomics, 2020, 38 : 1237 - 1245
[5] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Neuberger, Edward E.
Carlson, Josh J.
Veenstra, David L.
[J]. PHARMACOECONOMICS, 2020, 38 (11) : 1237 - 1245
[6] COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS
Siddiqui, J.
Bowditch, S.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S127 - S128
[7] Cannabidiol for Treatment of Patients With Seizures Associated With Lennox-Gastaut Syndrome
不详
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 546 - 546
[8] Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome
Clements, Karen M.
Skornicki, Michelle
O'Sullivan, Amy K.
[J]. EPILEPSY & BEHAVIOR, 2013, 29 (01) : 184 - 189
[9] COST-EFFECTIVENESS ANALYSIS OF ANTIEPILEPTIC DRUGS IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME
Clements, K. M.
Skornicki, M.
O'Sullivan, A. K.
[J]. VALUE IN HEALTH, 2012, 15 (04) : A144 - A144
[10] Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Lattanzi, S.
Trinka, E.
Russo, E.
Striano, P.
Citraro, R.
Silvestrini, M.
Brigo, F.
[J]. DRUGS OF TODAY, 2019, 55 (03) : 177 - 196

← 1 2 3 4 5 →